The Dutch ME/CFS Association (ME/CVS Vereniging) has posted the 80th in its video interview series, “Science to Patients” (“Wetenschap voor Patienten”), this time featuring British academic neuropsychiatrist Dr. Neil Harrison.
Dr. Harrison, of Sussex University, discusses the possible role of inflammation in the brains of ME/CFS patients in seven mini-interviews in the series. In the interviews, he said, “A number of groups, including my own, are looking to see whether we can develop MRI techniques to identify inflammation within the brain. At the moment, some of the data is quite hopeful.”
Asked whether he expected a breakthrough in ME/CFS research, he said, “My answer to this is very much yes. I think the developments that  I’ve seen in research funding within the UK, and the number of groups that are getting involved in investigating the physiology in ME, I think are very good signs that we should be hopeful of breakthroughs in ME research in the coming years.”
The full set of interview series can be found here and include interviews with clinician and researcher Professor Kenny De Meirleir of Vrije Universiteit Brussel, Belgium; cardiologist Professor FC Visser of the Erasmus University Medical Center, Rotterdam, the Netherlands; Dr. Charles Shepherd, medical advisor of the UK’s ME Association; Professor Julia Newton of Newcastle University, UK, who specialises in the autonomic nervous system; psychologist Professor Leonard Jason of  DePaul University, Chicago; neuroscientist Professor Alan Light, of the University of Utah; and clinician Dr. Lucinda Bateman of the Bateman Horne Center in Utah.
Interviews with Dr. Byron Hyde, founder of the Nightingale Research Foundation in Ottawa, Canada, have also been filmed and will be posted at a later date.
Interviews are either in English or subtitled in English: transcripts are also provided.
Since January 2014, ME/CVS Vereniging  has also published a free, bimonthly e-magazine in English, the ME Global Chronicle. Back-issues may be viewed and subscriptions set up here. Contributions can be submitted to [email protected].